Our PartnersOur Partners

We believe in the power of collaboration and strategic partnerships to drive innovation and accelerate progress in the pharmaceutical industry. We are building a network of partners who share our vision for a healthier future, expanding access to essential medicines, and enhancing the quality of life for patients.
https://theatcogroup.com/wp-content/uploads/2024/02/Alvimedica.jpg
Alvimedica is a manufacturer of coronary stents, balloon catheters, diagnostic and guiding catheters. The company was founded in 2007 by Turkish businessmen and scientists living in Denmark and Sweden. Alvimedica constantly pursue clinically innovative treatment and devices and wholeheartedly committed to improving minimally invasive procedures that prioritize the care for each patient and improve their quality of life.
https://theatcogroup.com/wp-content/uploads/2024/02/Celltrion.jpg
A leading force in the Korean pharmaceutical industry, Celltrion achieved what was thought impossible by launching the world’s first “antibody biosimilar”. Celltrion is Korea’s leading biologics company dedicated to research development, and manufacture of both biosimilars and new biopharmaceutical products. Celltrion Healthcare offers biologics to about 110 countries, along with more than 30 global partners around the world.
https://theatcogroup.com/wp-content/uploads/2024/02/Carbostent-and-Implant-Devices.jpg
The Carbostent and Implant Devices designs, develops, produces and distributes medical devices for the treatment of vascular disease. The devices include bare metal stents, drug-eluting stents, and angioplasty balloons. CID S.p.A. facility is designed for the manufacture of medical devices consistently with the requirements of Standards ISO 9001:2008 “Quality Management Systems – Requirements” and ISO 13485:2012 “Medical devices – Quality management systems – Requirements for regulatory purpose”
https://theatcogroup.com/wp-content/uploads/2024/02/Cardiome.jpg
Cardiome Pharma Corp. is a specialty biopharmaceutical company dedicated to the discovery, development and commercialization of new therapies that will improve the health of patients suffering from heart disease around the world. Cardiome’s mission is to offer patients and health care providers innovative therapeutic options that effectively, safely, and conveniently manage acute medical conditions to improve health and quality of life.
https://theatcogroup.com/wp-content/uploads/2024/02/Ferring.jpg
Ferring is a research-driven, specialty biopharmaceutical group committed to helping people build healthy families and live better lives. Ferring is a leader in reproductive medicine and maternal health, and in specialty areas within gastroenterology and urology.
https://theatcogroup.com/wp-content/uploads/2024/02/Fresenius-Kabi.jpg
Fresenius Kabi is a global healthcare company driven by a commitment to improve the quality of lives. Fresenius Kabi plays a vital role in the treatment of chronically and critically ill patients with four complementary business areas – Biopharma, Pharma (primarily IV drugs and infusion therapy), Medical Nutrition, and MedTech.
https://theatcogroup.com/wp-content/uploads/2024/02/Helsinn.jpg
Helsinn is a fully integrated global biopharma company focused on improving the lives of patients all over the world with a leading position in cancer supportive care and a focus on cancer therapeutics and rare diseases.
https://theatcogroup.com/wp-content/uploads/2024/02/Laboratoire-INNOTECH-International.jpg
With a footprint spanning more than 100 countries around the world, Laboratoire INNOTECH International specializes in the design and marketing of health products, medical devices, and pharmaceuticals which are designed to treat every-day pathologies including gynaecological disorders, venous insufficiency, anemia, and mineral deficiencies.
https://theatcogroup.com/wp-content/uploads/2024/02/Ipsen.jpg
As a mid-sized global biopharmaceutical company, Ipsen improves patients’ lives through research, innovation and the development of transformative medicines in Oncology, Rare Disease and Neuroscience.
https://theatcogroup.com/wp-content/uploads/2024/02/Medinova.jpg
Medinova is a niche provider with a clear emphasis on gynaecology, dermatology and other selected therapeutic fields. Building on our competences in the areas of prescription drugs (RX) as well as consumer healthcare products (OTC), Medinova has a solid base in the Swiss domestic market
https://theatcogroup.com/wp-content/uploads/2024/02/Rohto.jpg
Rohto Pharmaceutical Co., Ltd. is a multinational fast-moving consumer goods and OTC pharmaceutical corporation headquartered in Ikuno-ku, Osaka, Japan, with a presence in North America, Europe and Asia. Since its founding, Rohto has developed a wide range of products, from digestive medicines, to eye drops, dermatological ointment and beauty products.